Indicated for all types of skin
More serious but less common adverse effects require clinical vigilance: Pancreatitis : Patients should be counselled to stop the medication and seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back [1] [5] Gallbladder disease : Rapid weight loss associated with GLP-1 therapy may increase cholelithiasis risk [1] Hypoglycaemia : Particularly when used alongside insulin or sulphonylureas in diabetes management Diabetic retinopathy : Semaglutide requires caution in patients with pre-existing retinopathy, who should be monitored regularly [1] Renal impairment : Dehydration from gastrointestinal side effects may affect kidney function Specific considerations for individuals with eating disorders include the potential for GLP-1 medications to exacerbate restrictive eating patterns or mask hunger cues in vulnerable individuals
All treatment decisions involve individualized assessment, laboratory review when indicated, and ongoing monitoring
These medications mimic natural GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide) hormones, which reduce hunger, slow digestion, and improve insulin sensitivity, leading to sustainable fat loss
Sharon Osbourne Stopped Taking Ozempic Because She Couldn't Stop Losing Weight On Monday, Sharon Osbourne opened up about her recent weight loss on the U.K
Nature 600 , 408418 (2021)
